Skip to main content
Toggle navigation
Search
Home
Immunology
Home
Immunology
Immunology
Type here to filter the list
(235) Dupilumab improves signs and symptoms of Chronic Spontaneous Urticaria regardless of baseline body mass index
(236) Dupilumab monotherapy vs topical corticosteroids in prurigo nodularis: impact on signs and symptoms in the PRIME/PRIME2 studies
(237) Patient, Caregiver, and Physician Perspectives on the Burden of Disease in Uncontrolled Gout and its Treatment: Concept Elicitation
(238) Association between Dupilumab and repeated exacerbations of Chronic Obstructive Pulmonary Disease: BOREAS and NOTUS
(239) Dupilumab efficacy in patients with Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation with and without Emphysema
(240) Estimating the Economic Impact of Dupilumab in Type 2 Inflammatory Disease: Cost Offset Analysis of Atopic Dermatitis with Comorbid Asthma in the US Healthcare System
(241) Comparative effectiveness and economic evaluation of immunomodulatory therapies in generalized myasthenia gravis
(242) Treatment patterns and outcomes of Acthar Gel in ankylosing spondylitis and psoriatic arthritis: A physician-reported chart review
(243) Economic burden of allogeneic hematopoietic stem cell transplantation in severe leukocyte adhesion deficiency-I: a US database study of primary immunodeficiencies
(244) Healthcare costs associated with the care of patients with chronic inflammatory demyelinating polyneuropathy receiving immunoglobulin or neonatal fragment crystallizable receptor inhibitor therapies in the US
(245) Advancing managed care decision-making through cross-disease state understanding of type 2 (T2) inflammation to treat the underlying disease mechanism
(246) Quantifying the productivity burden of lupus nephritis and the potential value of obinutuzumab treatment
